Clinical Scorecard: Surgical Care Pathways for Elective Procedures Linked to Reduced Fracture Incidence and Improved Outcomes in Patients with Metastatic Bone Disease

At a Glance

Key Highlights

• Up to 20% of patients with metastatic bone disease experience pathologic fractures.
• Elective surgical pathways may improve survival and reduce healthcare costs.
• Emergent surgical interventions are associated with greater mortality compared to elective procedures.
• Study compares outcomes of elective versus emergent surgical care for metastatic bone disease.
• Data collected from multiple healthcare centers in southern Alberta, Canada.

Guideline-Based Recommendations

Diagnosis

• Identify patients with impending or actual pathologic fractures.
• Assess pain crises and loss of mobility as indicators for surgical intervention.

Management

• Consider elective surgery for patients with identified high-risk bone lesions.
• Utilize prophylactic fixation for impending pathologic fractures.

Monitoring & Follow-up

• Track post-operative survival rates and length of hospital stay.
• Monitor for 30-day readmissions following surgical procedures.

Risks

• Increased mortality associated with emergent surgical interventions.
• Potential for poor post-operative survival in patients with metastatic bone disease.

Patient & Prescribing Data

Patients with metastatic cancer undergoing orthopedic surgery.

Surgical intervention may be necessary for pain management and fracture prevention.

Clinical Best Practices

• Utilize a multidisciplinary approach for managing metastatic bone disease.
• Implement propensity score matching to balance confounders in surgical outcomes.
• Prioritize elective surgical pathways when feasible to improve patient outcomes.

Related Resources & Content

• Study References